Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

SCNI holding history

Scinai Immunotherapeutics Ltd. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SCNI overviewAll 13F holders of SCNIFull Q2 2026 holdings

Shares (Q2 2026)
62,257
Value
$15.7K
% of portfolio
<0.1%
Quarters held
6
Since Q4 2022
Holdings of SCNI by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202662,257$15.7K<0.1%+62,257NewHolders
Q1 20260$00.0%−34,562−100.0%Sold outHolders
Q4 202534,562$24.6K<0.1%+5,932+20.7%AddedHolders
Q3 202528,630$36.2K<0.1%+17,031+146.8%AddedHolders
Q2 202511,599$26.6K<0.1%+11,599NewHolders
Q2 20240$00.0%−1,221−100.0%Sold outConverted for a 1-for-10 splitHolders
Q1 202412,214$6.31K<0.1%+12,214NewHolders
Q1 20230$00.0%−17,459−100.0%Sold outHolders
Q4 202217,459$51.9K<0.1%+17,459NewHolders